APA (7th ed.) Citation

Magro, F., Fernandes, S., Patita, M., Arroja, B., Lago, P., Rosa, I., . . . Afonso, J. (2024). The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients. Journal of Crohn's & Colitis, 18(7), 1102. https://doi.org/10.1093/ecco-jcc/jjae014

Chicago Style (17th ed.) Citation

Magro, Fernando, et al. "The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients." Journal of Crohn's & Colitis 18, no. 7 (2024): 1102. https://doi.org/10.1093/ecco-jcc/jjae014.

MLA (9th ed.) Citation

Magro, Fernando, et al. "The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients." Journal of Crohn's & Colitis, vol. 18, no. 7, 2024, p. 1102, https://doi.org/10.1093/ecco-jcc/jjae014.